Orange Book product
SOLIFENACIN SUCCINATE 5MG
Orange Book ANDA 211423 · RISING PHARMA HOLDINGS INC · Prescription
Key facts
| Proprietary name | SOLIFENACIN SUCCINATE |
|---|---|
| Active ingredients | SOLIFENACIN SUCCINATE |
| Strength | 5MG |
| Dosage form | TABLET |
| Route | ORAL |
| Application | ANDA211423 |
| Applicant holder | RISING PHARMA HOLDINGS INC |
| Marketing status | Prescription |
| Therapeutic equivalence (TE) code | AB |
| Reference listed drug (RLD) | No |
| Reference standard (RS) | No |
| Approval date | Dec 11, 2019 |
At a glance
- 10–99 Marketed products with the same ingredient, strength and form
- 1–9 Products in this application
- No Reference listed drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Orange Book products
The FDA Orange Book lists approved drug products with their therapeutic equivalence (TE) codes, reference listed drugs and marketing status. Products approved before 1982 show an approval date of Jan 1, 1982.